These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23530301)

  • 21. Autoantibodies to glutamic acid decarboxylase and insulin in islet cell antibody positive presymptomatic type 1 diabetes mellitus: frequency and segregation by age and gender.
    Zimmet PZ; Elliott RB; Mackay IR; Tuomi T; Rowley MJ; Pilcher CC; Knowles WJ
    Diabet Med; 1994 Nov; 11(9):866-71. PubMed ID: 7705024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis.
    Mortensen HB; Swift PG; Holl RW; Hougaard P; Hansen L; Bjoerndalen H; de Beaufort CE; Knip M;
    Pediatr Diabetes; 2010 Jun; 11(4):218-26. PubMed ID: 19708904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes.
    Borg H; Gottsäter A; Fernlund P; Sundkvist G
    Diabetes; 2002 Jun; 51(6):1754-62. PubMed ID: 12031962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.
    Decochez K; Keymeulen B; Somers G; Dorchy H; De Leeuw IH; Mathieu C; Rottiers R; Winnock F; ver Elst K; Weets I; Kaufman L; Pipeleers DG; Gorus FK;
    Diabetes Care; 2000 Aug; 23(8):1072-8. PubMed ID: 10937500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.
    Zhu Y; Qian L; Liu Q; Zou J; Zhou Y; Yang T; Huang G; Zhou Z; Liu Y
    Diabetes Metab J; 2020 Apr; 44(2):260-266. PubMed ID: 31769235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and immunological characteristics in rapid-onset type 1 diabetes with hyperamylasemia].
    Zhang C; Zhou ZG; Zhang DM; Yang XL; Zhou M; Lin J; Huang G; Wang JP
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):967-71. PubMed ID: 16061004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
    Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
    Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis.
    Niskanen LK; Tuomi T; Karjalainen J; Groop LC; Uusitupa MI
    Diabetes Care; 1995 Dec; 18(12):1557-65. PubMed ID: 8722051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a caucasian population: are these type 1b diabetes cases?
    Tiberti C; Buzzetti R; Anastasi E; Dotta F; Vasta M; Petrone A; Cervoni M; Torresi P; Vecci E; Multari G; Di Mario U
    Diabetes Metab Res Rev; 2000; 16(1):8-14. PubMed ID: 10707033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
    Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
    Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of islet autoimmunity in the aetiology of different clinical subtypes of diabetes mellitus in young north Indians.
    Singh AK; Bhatia E; Dabadghao P; Bhatia V; Gellert SA; Colman PG
    Diabet Med; 2000 Apr; 17(4):275-80. PubMed ID: 10821293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The heterogeneity of islet autoantibodies and the progression of islet failure in type 1 diabetic patients.
    Liu J; Bian L; Ji L; Chen Y; Chen H; Gu Y; Ma B; Gu W; Xu X; Shi Y; Wang J; Zhu D; Sun Z; Ma J; Jin H; Shi X; Miao H; Xin B; Zhu Y; Zhang Z; Bu R; Xu L; Shi G; Tang W; Li W; Zhou D; Liang J; Cheng X; Shi B; Dong J; Hu J; Fang C; Zhong S; Yu W; Lu W; Wu C; Qian L; Yu J; Gao J; Fei X; Zhang Q; Wang X; Cui S; Cheng J; Xu N; Wang G; Han G; Xu C; Xie Y; An M; Zhang W; Wang Z; Cai Y; Fu Q; Fu Y; Zheng S; Yang F; Hu Q; Dai H; Jin Y; Zhang Z; Xu K; Li Y; Shen J; Zhou H; He W; Zheng X; Han X; Yu L; She J; Zhang M; Yang T
    Sci China Life Sci; 2016 Sep; 59(9):930-9. PubMed ID: 27225179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decline Pattern of Beta-cell Function in Adult-onset Latent Autoimmune Diabetes: an 8-year Prospective Study.
    Li X; Chen Y; Xie Y; Xiang Y; Yan X; Huang G; Zhou Z
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32307525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Islet cell antibodies and antibodies against glutamic acid decarboxylase in newly diagnosed adult-onset diabetes mellitus.
    Willis JA; Scott RS; Brown LJ; Forbes LV; Schmidli RS; Zimmet PZ; MacKay IR; Rowley MJ
    Diabetes Res Clin Pract; 1996 Jul; 33(2):89-97. PubMed ID: 8879963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with beta-selective GAD-specific islet cell antibodies.
    Wagner R; McNally JM; Bonifacio E; Genovese S; Foulis A; McGill M; Christie MR; Betterle C; Bosi E; Bottazzo GF
    Diabetes; 1994 Jul; 43(7):851-6. PubMed ID: 7912208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA).
    Lohmann T; Kellner K; Verlohren HJ; Krug J; Steindorf J; Scherbaum WA; Seissler J
    Diabetologia; 2001 Aug; 44(8):1005-10. PubMed ID: 11484077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type 1 diabetes in insulin-treated adult-onset diabetic subjects.
    Willis J; Scott R; Brown L; Zimmet P; MacKay I; Rowley M
    Diabetes Res Clin Pract; 1998 Oct; 42(1):49-53. PubMed ID: 9884033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Non classical subtypes of diabetes mellitus].
    Raddatz V; Durruty P; Briones G; López G; Soto N; García de los Ríos M
    Rev Med Chil; 2001 Aug; 129(8):853-60. PubMed ID: 11680958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutamic acid decarboxylase autoantibody-positivity post-partum is associated with impaired β-cell function in women with gestational diabetes mellitus.
    Lundberg TP; Højlund K; Snogdal LS; Jensen DM
    Diabet Med; 2015 Feb; 32(2):198-205. PubMed ID: 25345799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age.
    Borg H; Gottsäter A; Landin-Olsson M; Fernlund P; Sundkvist G
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3032-8. PubMed ID: 11443164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.